Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent

MeSH terms

• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
• Bridged Bicyclo Compounds, Heterocyclic* / administration & dosage
• Bridged Bicyclo Compounds, Heterocyclic* / therapeutic use
• Cladribine* / administration & dosage
• Cladribine* / therapeutic use
• Cytarabine* / administration & dosage
• Cytarabine* / therapeutic use
• Drug Resistance, Neoplasm / drug effects
• Female
• Humans
• Leukemia, Myeloid, Acute* / drug therapy
• Leukemia, Myeloid, Acute* / genetics
• Leukemia, Myeloid, Acute* / pathology
• Male
• Middle Aged
• Recurrence
• Sulfonamides* / administration & dosage
• Sulfonamides* / therapeutic use
• Treatment Outcome